By the 1950s, the use of
organophosphate insecticides was well established, despite their known toxicity to mammals. For example,
parathion had been developed in the 1940s and became widely used in agriculture despite its known oral toxicity. Many chemical companies continued to research this type of
acetylcholinesterase inhibitor, seeking to develop alternatives which had greater human safety while retaining their activity on pests. In 1952, Dr. Ranajit Ghosh, a chemist at
Imperial Chemical Industries (ICI), investigated
organophosphate esters of substituted amino
ethanethiols and compared their properties to parathion, which ICI was already marketing as Fosferno. Amiton was found to be much less toxic than parathion to many insects but was considerably more toxic to
acarid pests such as the spider-mite
Tetranychus telarius.
Field trials demonstrated its utility against the red mite
Panonychus ulmi: a single treatment of 20 ppm was shown to give season-long control. This led to plans to market the compound under the
trade name Tetram but the oral LD50 of 5 mg/kg to rats meant that the compound was comparable to parathion in mammalian toxicity while having a more limited use, so its development was halted as not being commercially viable. The
British Government was aware of the extreme toxicity of organophosphate compounds and some of the ICI materials were sent to
Porton Down,
Britain's chemical weapons research facility, for evaluation. This led to the identification of a new class of
nerve agents, later named
V (venomous) agents. Britain officially renounced chemical and biological weapons in 1956, but the United States continued research into this class, leading to the mass production of
VX—a chemically similar but far more toxic compound—in 1961. Amiton was no longer pursued for chemical warfare or as a pesticide. ==Synthesis==